The 47 references in paper A. Khorinko V., D. Amarantov G., P. Kosareva V., Андрей Хоринко Витальевич, Дмитрий Амарантов Георгиевич, Полина Косарева Владимировна (2017) “Роль нарушения клеточно-матриксных взаимодействий в патогенезе прогрессирования фиброза легких // The Role of the Disorders of Cell Matrix Interactions in the Pathogenesis of Pulmonary Fibrosis Progression” / spz:neicon:anatomy:y:2016:i:3:p:84-89

1
Итмезех А. Механизмы развития пневмопатии при различных путях проникновения эндотоксинов в легочную ткань / А. Итмезех, Ю.В. Дегтярь // Бюллетень Волгоградского научного центра РАМН. 2005. No 1. С. 34–35.
(check this in PDF content)
2
Datta A. Novel therapeutic approaches for pulmonary fibrosis Pulmonary fibrosis British Journal of Pharmacology / A. Datta, C.J. Scotton, R.C. Chambers // Themed Issue: Respiratory Pharmacology. 2011. V. 163. P. 141–172.
(check this in PDF content)
3
Maher T. M. Pirfenidone in idiopathic pulmonary fibrosis / T.M. Maher // Drugs Today (Barc). 2010. Vol. 46. P. 473–482.
(check this in PDF content)
4
Survival of Apligraf in acute human wounds / M. Griffiths [et al]. // Tissue Eng. 2004. Vol. 10. No 7–8. P. 1180–1195.
(check this in PDF content)
5
Scotton C. J. Molecular targets in pulmonary fibrosis: the myofibroblast in focus / C.J. Scotton, R.C. Chambers // Chest. 2007. Vol. 132. P. 1311– 1321.
(check this in PDF content)
6
Moodley Y. P. Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL-induced apoptosis / Y.P. Moodley, P. Caterina, A.K. Scaffidi // J. Pathol. 2004. Vol. 202. P. 486–495.
(check this in PDF content)
7
Covering by a flap induces apoptosis of granulation tissue myofibroblasts and vascular cells / S. Garbin [et al.] // Wound Repair Regen. 1996. Vol. 4. No 2. P. 244–251.
(check this in PDF content)
8
Tuong V. Markers of cell proliferation, apoptosis and angiogenesis in Remodeling of bronchoalveolar duct junctions. Polish Histochemichal et Cytological Society / V. Tuong, S. Demoura, E. Kogan // Folia Histochemica et Cytobiologica. 2008. V. 46, N 2. P. 62.
(check this in PDF content)
9
Demoura S. Apoptosis, cell proliferation and angiogenesis in progression of different variants of idiopathic interstitial pneumonia / S. Demoura, V. Tuong, E. Kogan // European Respiratory journal. 2007. Vol. 30. No 51. P. 3405.
(check this in PDF content)
10
Kogan E. Initiating morphological and molecular events at bronchoalveolar duct junctions in progression of idiopathic pulmonary fibrosis / E. Kogan, V. Tuong, S. Demoura // Histopathology. 2008. Vol. 53. No 1. P. 350–351.
(check this in PDF content)
11
Moodley Y. P. Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/ gp130-mediated cell signaling and proliferation / Y.P. Moodley, A.K. Scaffidi, N.L. // Misso Am J Pathol. 2003. Vol. 163. P. 345–354.
(check this in PDF content)
12
Scotton C. J. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury / C.J. Scotton, M.A. Krupiczojc, M.J. Konigshoff // Clin Invest. 2009. Vol. 119. P. 2550–2563.
(check this in PDF content)
13
Moustakas A. TGFβ and matrix-regulated epithelial to mesenchymal transition / A. Moustakas, P. Heldin // Biochimica et Biophysica Acta (BBA) – General Subjects. 2014. Vol. 1840. No 8. P. 2621– 2634.
(check this in PDF content)
14
Кузник Б. И. Клеточные и молекулярные механизмы регуляции системы гемостаза в норме и патологии / Б.И. Кузник. Чита: Экспресс-издательство, 2010. 832 c.
(check this in PDF content)
15
Кетлинский С. А. Цитокины / С.А. Кетлинский, А.С. Симбирцев. СПб.: Фолиант, 2008. 552 c.
(check this in PDF content)
16
Subramanian S. V. Induction of vascular smooth muscle alpha-actin gene transcription in transforming growth factor beta1-activated myofibroblasts mediated by dynamic interplay between the Pur repressor proteins and Sp1/Smad coactivators / S.V. Subramanian, J.A. Polikandriotis, R.J. Kelm // Mol Biol Cell. 2004. Vol. 15. P. 4532–4543.
(check this in PDF content)
17
Leask A. Signaling in fibrosis: targeting the TGF beta, endothelin-1 and CCN2 axis in scleroderma / A. Leask. Front Biosci (Elite Ed). 2009. Vol. 1. P. 115–122.
(check this in PDF content)
18
Kogan E. Matrix metalloproteinases and their tissue inhibitors in Remodeling of bronchoalveolar duct junctions / E. Kogan, V. Tuong, S. Demoura // Polish Histochemichal et Cytological Society. Folia Histochemica et Cytobiologica. 2008. Vol. 46. No 2. P. 98: P3.44.
(check this in PDF content)
19
Kogan E. MMPs and TIMP-4 in remodeling of extracellular matrix, fibrosis, cell proliferation in different variants of idiopathic chronic interstitial pneumonias / E. Kogan, V. Тuong, S. Demoura // Virchows archive. 2007. Vol. 451. No 2. P. 21–25.
(check this in PDF content)
20
Kolodsick J. E. Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts / J.E. Kolodsick, G.B. Toews, C. Jakubzick // J. Immunol. 2004. Vol. 172. P. 4068–4076.
(check this in PDF content)
21
Xaubet A. Cyclooxygenase-2 is up-regulated in lung parenchyma of chronic obstructive pulmonary disease and down-regulated in idiopathic pulmonary fibrosis / A. Xaubet, J. Roca-Ferrer, L. Pujols // Sarcoidosis Vasc. Diffuse Lung Dis. 2004. Vol. 21. P. 35–42.
(check this in PDF content)
22
Bauman K. A. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice / K.A. Bauman, S.H. Wettlaufer, K. Okunishi // J. Clin Invest. 2010. Vol. 120. P. 1950–1960.
(check this in PDF content)
23
Epithelial-mesenchymal transitions in development and disease / J.P. Thiery, H. Acloque, R.Y. Huang, M.A. Nieto // Cell. 2009. Vol. 139. No 5. P. 871–890.
(check this in PDF content)
24
Kim K. K. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis / K.K. Kim, Y. Wei, C. Szekeres // J. Clin. Invest. 2009. Vol. 119. P. 213–224.
(check this in PDF content)
25
Котенко К. Эпителиально-мезенхимальный переход и опухолевая прогрессия / К. Котенко // Онкология. Огляд. 2014: ZU_2014_Onko_3.qxd 27.06.2014 15:45; 39; http://healthua.com/pics/pdf/ZU_2014_Onko_3/39.pdf.
(check this in PDF content)
26
Волков К. С. Роль эпителиальномезенхимального перехода в патогенезе заживления кожных ран / К.С. Волков, С.Б. Крамар // Morphologia (Морфологiя). 2015. Т. 9. No 2. С. 7–10.
(check this in PDF content)
27
Wynn T. A. Cellular and molecular mechanisms of fibrosis / T.A.Wynn // The Journal of Pathology. 2008. Vol. 214. No 2. P. 199–210.
(check this in PDF content)
28
Осинский С. П. Микроокружение опухолевых клеток и опухолевая прогрессия. Факторы стромального микроокружения / С.П. Осинский // Здоров’я УкраÏни. 2013. No 6. С. 36–39.
(check this in PDF content)
29
Gunther A. Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits / A. Gunther, N. Lubke, M. Ermert // Am. J. Respir. Crit. Care Med. 2003. Vol.168. P. 1358–1365.
(check this in PDF content)
30
Epithelial-Mesenchymal Transition in tumor microenvironment / Y. Jing [et al.] // Cell Biosci. 2011. Vol. 1. P. 29.
(check this in PDF content)
31
Lindsey S. Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition / S. Lindsey, S.A. Langhans // Front. Oncol. 2014. Vol. 4. P. 358.
(check this in PDF content)
32
Lamouille S. Molecular mechanisms of epithelialmesenchymal transition / S. Lamouille, J. Xu, R. Derynck // Nat. Rev. Mol. Cell. Biol. 2014. Vol. 15. No 3. P. 178–196.
(check this in PDF content)
33
Yang J. Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis / J. Yang, R.A. Weinberg // Developmental Cell. 2008. Vol. 14. No 6. P. 818–829.
(check this in PDF content)
34
Royer C. Epithelial cell polarity: a major gatekeeper against cancer? / C. Royer, X. Lu // Cell Death Differ. 2011. Vol. 18. No 9. P. 1470–1477.
(check this in PDF content)
35
Xu J. TGF-induced epithelial to mesenchymal transition / J. Xu, S. Lamouille, R. Derynck // Cell Research. 2009. Vol. 19. P. 156–172.
(check this in PDF content)
36
Acquisition of Epithelial-Mesenchymal Transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of Notch signaling pathway / Z. Wang, Y. Li, D. Kong, S. Banerjee // Cancer Res. 2009. Vol. 69. No 6. P. 2400–2407.
(check this in PDF content)
37
Nieto M. A. Epithelial-Mesenchimal transition in development and desease: old views and new perspectives / M.A. Nieto // Int. J. Dev. Biol. 2008. Vol. 52. P. 1–7.
(check this in PDF content)
38
Heng D. Y. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factortargeted agents: results from a large, multicenter study / D.Y. Heng, W. Xie, M.M. Regan // J. Clin. Oncol. 2009. Vol. 27. P. 5794–5799.
(check this in PDF content)
39
Кудряшов А. Г. Морфологические особенности эпителиально-мезенхимальной трансформации в карциномах почки и их связь с клиническим течением опухоли / А.Г. Кудряшов, И.В. Василенко, А.С. Малашкевич // Український Журнал Хірургії. 2011. Т. 6. No15. С. 147–154.
(check this in PDF content)
40
Moore B. B. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis / B.B. Moore, L. Murray, A. Das // Am. J. Respir. Cell. Mol. Biol. 2006. Vol. 35. P. 175–181.
(check this in PDF content)
41
Mehrad B. Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis / B. Mehrad, M.D. Burdick, R.M. Strieter // Int. J. Biochem. Cell. Biol. 2009. Vol. 41. P. 1708–1718.
(check this in PDF content)
42
Hashimoto N. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis / N. Hashimoto, S.H. Phan, K. Imaizumi // Am. J. Respir. Cell. Mol. Biol. 2010. Vol. 43. P. 161–172.
(check this in PDF content)
43
Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing / N.S. Greaves, K.J. Ashcroft, M. Baguneid, A. Bayat // J. Dermatol. Sci. 2013. Vol. 72. No 3. P. 206–217.
(check this in PDF content)
44
Novikov N. Y. Pathomorphological changes acute lung injury / N.Y. Novikov, S.I. Dolomatov, T.I. Prokopenko // J. Health Sci. 2011. Vol. 1. No 4. P. 173–178.
(check this in PDF content)
45
Molecular Mediators of Angiogenesis / A.A. Ucuzian, A.A. Gassman, A.T. East, H.P. Greisler // J. Burn. Care Res. 2010. Vol. 31. No 1. P. 158.
(check this in PDF content)
46
Chow K. Dysfunctional resident lung mesenchymal stem cells contribute to pulmonary microvascular remodeling / K. Chow, J.P. Fessel, E.P. Schmidt // Pulmonary Circulation. 2013. Vol. 3. No 1. P. 31–50.
(check this in PDF content)
47
Scotton C. J. Pulmonary fibrosis British Journal of Pharmacology / C.J. Scotton, R.C. Chambers // 2011. Vol. 163. P. 141–172. Информация об авторах
(check this in PDF content)